Pulmonary Dysfunction Is Possibly a Marker of Malnutrition and Inflammation but Not Mortality in Patients with End-Stage Renal Disease

Publisher： Karger

E-ISSN： 1660-2110|111|1|c1-c6

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.111, Iss.1, 2008-11, pp. : c1-c6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Value of the Malnutrition-Inflammation-Atherosclerosis Syndrome for Long-Term Prediction of Cardiovascular Mortality in Patients with End-Stage Renal Disease: A 5-Year Prospective Study

By  

Nephron Clin Pract, Vol. 108, Iss. 2, 2008-01 ,pp. : c99-c105

Karger

Access to resources Recommend Favorite

Hypertension – A Possible Vulnerability Marker for Depression in Patients with End-Stage Renal Disease

By  

Nephron Clin Pract, Vol. 102, Iss. 1, 2005-09 ,pp. : c43-c50

Karger

Access to resources Recommend Favorite

Deferasirox in thalassemia patients with end‐stage renal disease

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 91, Iss. 10, 2016-10 ,pp. : E456-E457

John Wiley & Sons Inc

Access to resources Recommend Favorite

Baseline Oxysterols and Other Markers of Oxidative Stress, Inflammation and Malnutrition in the Vitamin E and Intima Media Thickness Progression in End-Stage Renal Disease (VIPER) Cohort

By  

Nephron Clin Pract, Vol. 100, Iss. 4, 2005-04 ,pp. : c111-c119

Karger

Access to resources Recommend Favorite

The Impact of Type 2 Diabetes on Mortality in End-Stage Renal Disease Patients Differs between Genders

By  

Nephron Clin Pract, Vol. 112, Iss. 4, 2009-06 ,pp. : c268-c275

Karger

Access to resources Recommend Favorite